Trial intelligence / Profile preview

Glyburide vs Placebo for Mild Gestational Diabetes

NCT00744965Phase 4Completed

Sponsor
UT Southwestern Medical Center
Start
Sep 2008
Primary completion
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of glibenclamide in gestational diabetes mellitus (GDM), sponsored by UT Southwestern Medical Center. Started Sep 2008; status: completed.

02

Drugs

glibenclamide
03

Conditions

gestational diabetes mellitus (GDM)

Beyond the preview

Go deeper on NCT00744965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00744965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call